MDM2 309T&gt;G polymorphism and risk of lung cancer in a Korean population

Sun Ha Park; Jin Eun Choi; Eun Jin Kim; Jin Sung Jang; Hyung Soo Han; Won Kee Lee; Young Mo Kang; Jae Yong Park

doi:10.1016/j.lungcan.2006.06.008

journal article Oct 01, 2006

MDM2 309T>G polymorphism and risk of lung cancer in a Korean population

Sun Ha Park Jin Eun Choi Eun Jin Kim Jin Sung Jang Hyung Soo Han

Won Kee Lee

Young Mo Kang

Jae Yong Park

Lung Cancer Vol. 54 No. 1 pp. 19-24 · Elsevier BV

View at Publisher Save 10.1016/j.lungcan.2006.06.008

Topics

No keywords indexed for this article. Browse by subject →

References

34

[1]

Sellers "Evidence of Mendelian inheritance in the pathogenesis of lung cancer" J Natl Cancer Inst (1990) 10.1093/jnci/82.15.1272

[2]

Shields "Cancer risk and low-penetrance susceptibility genes in gene-environment interactions" J Clin Oncol (2000) 10.1200/jco.2000.18.11.2309

[3]

Sunaga "Contribution of the NQQ1 and GSTT1 polymorphisms to lung adenocarcinoma susceptibility" Cancer Epidemiol Biomark Prev (2002)

[4]

Sugimura "hOGG1 Ser326Cys polymorphism and lung cancer susceptibility" Cancer Epidemiol Biomark Prev (1999)

[5]

Chae "O-Alkylguanine-DNA alkyltransferase gene polymorphisms and the risk of primary lung cancer" Mol Carcinongenesis (2006) 10.1002/mc.20171

[6]

Son JW, Kang HG, Chae MH, Choi JE, Park JM, Lee WK, et al. Polymorphisms in the caspase-8 gene and the risk of lung cancer. Cancer Genet Cytogenet, in press.

[7]

Freedman "Functions of the MDM2 oncoprotein" Cell Mol Life Sci (1999) 10.1007/s000180050273

[8]

Moll "The MDM2-p53 interaction" Mol Cancer Res (2003)

[9]

Woods "Regulation of p53 function" Exp Cell Res (2001) 10.1006/excr.2000.5141

[10]

Xiao "Interaction between the retinoblastoma protein and the oncoproteins MDM2" Nature (1995) 10.1038/375694a0

[11]

Sun "p53-independent role of MDM2 in TGF-beta1 resistance" Science (1998) 10.1126/science.282.5397.2270

[12]

Hsieh "RB regulates the stability and the apoptotic function of p53 via MDM2" Mol Cell (1999) 10.1016/s1097-2765(00)80309-3

[13]

Iwakuma "MDM2 an introduction" Mol Cancer Res (2003)

[14]

Aikawa "MDM2 expression is associated with progress of disease and WAF1 expression in resected lung cancer" Int J Mol Med (2000)

[15]

Ko "MDM2 mRNA expression is a favorable prognostic factor in non-small cell lung cancer" Int J Cancer (2000) 10.1002/1097-0215(20000520)89:3<265::aid-ijc9>3.0.co;2-n

[16]

Eymin "Mdm2 overexpression and p14ARF inactivation are two mutually exclusive events in primary human lung tumors" Oncogene (2002) 10.1038/sj.onc.1205359

[17]

Mori "p53 apoptotic pathway molecules are frequently and simultaneously altered in nonsmall cell lung carcinoma" Cancer (2004) 10.1002/cncr.20164

[18]

Bond "A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans" Cell (2004) 10.1016/j.cell.2004.11.022

[19]

Genetic polymorphisms in cell cycle regulatory genesMDM2 andTP53 are associated with susceptibility to lung cancer

Xuemei Zhang, Xiaoping Miao, Yuxi Guo et al.

Human Mutation 2006 10.1002/humu.20277

[20]

Lind "Association of a functional polymorphism in the promoter of the MDM2 gene with risk of nonsmall cell lung cancer" Int J Cancer (2006) 10.1002/ijc.21872

[21]

Park "Relationship between cyclooxygenase 8473T>C polymorphism and risk of lung cancer: a case–control study" BMC Cancer (2006) 10.1186/1471-2407-6-70

[22]

Park "Caspase 9 promoter polymorphisms and risk of primary lung cancer" Hum Mol Genet (2006) 10.1093/hmg/ddl119

[23]

Sotamaa "p53 codon 72 and MDM2 SNP309 polymorphisms and age of colorectal cancer onset in Lynch syndrome" Clin Cancer Res (2005) 10.1158/1078-0432.ccr-05-1139

[24]

Hu "Genetic variants in the MDM2 promoter and lung cancer risk in a Chinese population" Int J Cancer (2006) 10.1002/ijc.21463

[25]

Millikan "No association between the MDM2-309T/G promoter polymorphism and breast cancer in African–Americans or Whites" Cancer Epidemiol Biomark Prev (2006) 10.1158/1055-9965.epi-05-0692

[26]

Alhopuro "The MDM2 promoter polymorphism SNP309T→G and the risk of uterine leiomyosarcoma, colorectal cancer, and squamous cell carcinoma of the head and neck" J Med Genet (2005) 10.1136/jmg.2005.031260

[27]

Hong "The role of p53 and MDM2 polymorphisms in the risk of esophageal squamous cell carcinoma" Cancer Res (2005) 10.1158/0008-5472.can-05-1460

[28]

MDM2 gene promoter polymorphisms and risk of lung cancer: a case-control analysis

G. Li

Carcinogenesis 2006 10.1093/carcin/bgl047

[29]

Ma "Polymorphisms in the MDM2 promoter and risk of breast cancer: a case–control analysis in a Chinese population" Cancer Lett (2005)

[30]

Houlston "Detecting low penetrance genes in cancer: the way ahead" J Med Genet (2000) 10.1136/jmg.37.3.161

[31]

Goldgar "Population aspects of cancer genetics" Biochimie (2002) 10.1016/s0300-9084(01)01357-8

[32]

Shen "A novel polymorphism in human cytosine DNA-methyltransferase-3B promoter is associated with an increased risk of lung cancer" Cancer Res (2002)

[33]

Park "Polymorphisms of the DNA repair gene Xeroderma Pigmentosum group A and risk of primary lung cancer" Cancer Epidemiol Biomark Prev (2002)

[34]

Lee "Characteristics of lung cancer in Korea" Lung Cancer (2000) 10.1016/s0169-5002(00)00126-4

Cited By

36

MDM2 SNP309 contributes to tumor susceptibility: A meta-analysis

Xiaoman Wo, Dong Han · 2011

Journal of Genetics and Genomics

MDM2 SNP309 and cancer risk: a combined analysis

Stefan Wilkening, Justo Lorenzo Bermejo · 2007

Carcinogenesis

Metrics

36

Citations

34

References

Details

Published: Oct 01, 2006
Vol/Issue: 54(1)
Pages: 19-24
License: View

Authors

Department of Physiology, School of Medicine, Clinical Omics Institute, Kyungpook National University, Daegu 41944, Republic of Korea

W

Won Kee Lee

Department of Statistics, School of Medicine, Kyungpook National University, Daegu, Korea.

Y

Young Mo Kang

Preclina Inc., 719 & 1302, Teratower B , 167, Songpa-daero, Songpa-gu, Seoul ,; Division of Rheumatology, Department of Internal Medicine, Kyungpook National University School of Medicine , Daegu,

J

Jae Yong Park

Cite This Article

Sun Ha Park, Jin Eun Choi, Eun Jin Kim, et al. (2006). MDM2 309T>G polymorphism and risk of lung cancer in a Korean population. Lung Cancer, 54(1), 19-24. https://doi.org/10.1016/j.lungcan.2006.06.008

MDM2 309T&gt;G polymorphism and risk of lung cancer in a Korean population

You May Also Like

MDM2 309T>G polymorphism and risk of lung cancer in a Korean population